Recent advances in neoantigen research have accelerated the development and regulatory
approval of tumor immunotherapies, including cancer vaccines, adoptive cell therapy and …

Cervical cancer is now the fourth most prevalent malignancy in women worldwide,
representing a tremendous burden of cancer. The heterogeneity of complex tumor …

Vaccines are one of the most effective medical interventions to combat newly emerging and
re-emerging diseases. Prophylactic vaccines against rabies, measles, etc., have excellent …

Background and aim: Human papillomavirus (HPV) is sexually transmitted, one of the three
most common sexually transmitted infections (STIs) in both males and females, and the most …

Cancer becomes one of the main causes of human deaths in the world due to the high
incidence and mortality rate and produces serious economic burdens. With more and more …

Ethnopharmacological relevance Natural products play a critical role in drug development
and is emerging as a potential source of biologically active metabolites for therapeutic …

Novel effective drugs or therapeutic vaccines have been already developed to eradicate
viral infections. Some non-viral carriers have been used for effective drug delivery to a target …

Prophylactic vaccines against human papillomavirus (HPV) have proven efficacy in those
who have not been infected by the virus. However, they do not benefit patients with …

Persistent infection of human papillomavirus (HPV) and immune escape are the main
causes of cervical cancer. E6/E7 encoded by HPV16 may be closely related to …

High‐risk human papillomaviruses (HR‐HPVs) cause various malignancies in the
anogenital and oropharyngeal regions. About 70% of cervical and oropharyngeal cancers …